Week 7: Analysis of HLA Gene Editing Study by Ji et al. (2023)

This week, I decided to move forward with doing a systematic review. With this shift, I started reading and analyzing individual research papers in depth and trying to extract their results.

To start this process, I worked through one of the main papers I selected this week, “Genome editing HLA alleles for a pilot immunocompatible hESC line in a Chinese hESC bank for cell therapies” by Ji et al. (2023). In this study, the researchers aimed to reduce immune rejection in stem cell–derived tissues by editing specific HLA genes. They created a modified stem cell line by removing certain HLA components that trigger immune responses while keeping one key HLA type to maintain some level of immune recognition. They then tested these edited cells using a series of experiments, including co-culture with immune cells and testing in animal models. They found that the edited cells triggered much weaker T-cell responses while still avoiding increased attack from natural killer (NK) cells.

This paper provides evidence that gene editing can successfully reduce certain immune responses, particularly those driven by T cells. At the same time, it shows that these edits must be carefully designed to avoid unintended consequences, such as activating other parts of the immune system. It helps answer how effective gene-editing strategies are in reducing immune rejection and what factors influence that effectiveness. It also shows that targeting multiple genes and balancing immune pathways can lead to better outcomes compared to simpler approaches.